October 30, 2024 - 9:00am to 11:00am DST
Featuring> George Daston – Victor Mills Society Research Fellow, Procter & Gamble> Ron Filler – President & CEO, Drug Development Consultants, Inc.> Jeffrey Pitt - Lead Toxicologist, IFF> Teresa Wegesser - Scientific Associate Director, Amgen
Read-across is the only accepted alternative to animal testing at present. Cheminformatic approaches to choose and assess the suitability of analogs for read-across have been developed, and high-content biotechnology methods such as global gene expression analysis have been used to prove biological similarity of analogs.
IPEC-Americas901 N Glebe RoadSuite 500Arlington, VA 22203571-814-3449
Contact UsGetting Here
JoinBenefitsTop 10 Reasons to Join
About UsTerms of Use